Recent study results indicate the participation of CD163+ TAMs (M2) infiltrations in the invasive front of a tumor in EMT process, their association with mesenchymal-circulating tumor-cell (CTC) ratio, and poor prognosis in CRC patients. The gene discussed is CD163; the disease is neoplasm.